UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 183

Sortiert nach

Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial

Gut, 2020-07, Vol.69 (7), p.1206

2020

Volltextzugriff (PDF)

Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis

The lancet. Gastroenterology & hepatology, 2021-12, Vol.6 (12), p.1002-1014

2021

Volltextzugriff (PDF)

Adalimumab Monotherapy and a Combination with Azathioprine for Crohn’s Disease: A Prospective, Randomized Trial

Journal of Crohn's and colitis, 2016-11, Vol.10 (11), p.1259-1266

2016

Volltextzugriff (PDF)

Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica

Neurology, 2011-08, Vol.77 (7), p.659

2011

Volltextzugriff (PDF)

A randomized trial of methotrexate versus azathioprine for severe atopic eczema

Journal of allergy and clinical immunology, 2011-08, Vol.128 (2), p.353-359

2011

Volltextzugriff (PDF)

Efficacy of optimised thiopurine therapy in patients with moderate-to-severe ulcerative colitis: retrospective long-term follow-up from two randomised trials

Scandinavian journal of gastroenterology, 2024-06, Vol.59 (6), p.669-673

2024

Volltextzugriff (PDF)

Budesonide versus Prednisone with Azathioprine for the Treatment of Autoimmune Hepatitis in Children and Adolescents

The Journal of pediatrics, 2013-11, Vol.163 (5), p.1347-1353.e1

2013

Volltextzugriff (PDF)

A real‐world study focused on the long‐term efficacy of mycophenolate mofetil as first‐line treatment of autoimmune hepatitis

Alimentary pharmacology & therapeutics, 2016-05, Vol.43 (10), p.1035-1047

2016

Volltextzugriff (PDF)

The efficacy and safety of immunosuppressive therapies in the treatment of IgA nephropathy: A network meta-analysis

Scientific reports, 2020-04, Vol.10 (1), p.6062, Article 6062

2020

Volltextzugriff (PDF)

Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximab

Digestive and liver disease, 2024-05, Vol.56 (5), p.737-743

2024

Volltextzugriff (PDF)

Mucosal Healing in Paediatric Patients with Moderate-to-Severe Luminal Crohn’s Disease Under Combined Immunosuppression: Escalation versus Early Treatment

Journal of Crohn's and colitis, 2016-11, Vol.10 (11), p.1279-1286

2016

Volltextzugriff (PDF)

Withdrawal of thiopurines in Crohn’s disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2)

Journal of gastroenterology, 2019-10, Vol.54 (10), p.860-870

2019

Volltextzugriff (PDF)

Randomised clinical trial: individualised vs. weight‐based dosing of azathioprine in Crohn's disease

Alimentary pharmacology & therapeutics, 2014-01, Vol.39 (2), p.163-175

2014

Volltextzugriff (PDF)

Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?

Inflammatory bowel diseases, 2017-11, Vol.23 (11), p.2011-2017

2017

Volltextzugriff (PDF)

Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial

Kidney international, 2006-08, Vol.70 (4), p.732-742

2006

Volltextzugriff (PDF)

Immune thrombocytopenia: Effectiveness of frontline steroids and comparison of azathioprine, splenectomy, and rituximab as second‐line treatment

European journal of haematology, 2018-10, Vol.101 (4), p.549-555

2018

Volltextzugriff (PDF)

Azathioprine in severe uveitis of Behçet's disease

Arthritis care & research (2010), 2010-12, Vol.62 (12), p.1733-1738

2010

Volltextzugriff (PDF)

Concerns and Side Effects of Azathioprine During Adalimumab Induction and Maintenance Therapy for Japanese Patients With Crohn's Disease: A Subanalysis of a Prospective Randomised Clinical Trial [DIAMOND Study]

Journal of Crohn's and colitis, 2019-09, Vol.13 (9), p.1097-1104

2019

Volltextzugriff (PDF)

Belimumab in refractory organizing pneumonia associated with systemic lupus erythematosus: a case report

Lupus, 2019-04, Vol.28 (4), p.565-568

2019

Volltextzugriff (PDF)

Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial

The Lancet (British edition), 2006-03, Vol.367 (9513), p.839-846

2006

Volltextzugriff (PDF)

Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease

World journal of gastroenterology : WJG, 2017-01, Vol.23 (3), p.414-425

2017

Volltextzugriff (PDF)

Azathioprine discontinuation earlier than 6 months in Crohn's disease patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation

European journal of gastroenterology & hepatology, 2015-04, Vol.27 (4), p.436-441

2015

Volltextzugriff (PDF)

Azathioprine Therapy in a Pediatric TPMT-Deficient Patient-Still an Option

Therapeutic drug monitoring, 2017-02, Vol.39 (1), p.1

2017

Volltextzugriff (PDF)

Efficacy of Sustained Combination Therapy for at Least 6 Months with Thiopurines and Infliximab in Patients with Ulcerative Colitis in Clinical Remission: A Retrospective Multicenter French Experience

Journal of Crohn's and colitis, 2015-03, Vol.9 (3), p.252-258

2015

Volltextzugriff (PDF)

Treatment efficacy and safety of low-dose azathioprine in chronic active ulcerative colitis patients: A meta-analysis and systemic review

Journal of digestive diseases, 2016-10, Vol.17 (10), p.652-659

2016

Volltextzugriff (PDF)

1 – 25 von 183

Suche als RSS-Feed

Aktive Filter

ThemaImmunosuppressive Agents - Therapeutic Use

ThemaTreatment Outcome

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(138)

Publikationsform

Artikel
(183)

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(179)
Azathioprine - Therapeutic Use
(152)
Science & Technology
(150)
Life Sciences & Biomedicine
(147)
Female
(130)
Male
(130)
Immunosuppressive Agents - Administration & Dosage
(112)
Adult
(108)
Azathioprine - Administration & Dosage
(100)
Middle Aged
(95)
Drug Therapy, Combination
(77)
Gastroenterology & Hepatology
(56)
Azathioprine
(54)
Biological And Medical Sciences
(54)
Medical Sciences
(54)
Adolescent
(53)
Retrospective Studies
(50)
Aged
(47)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial

Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis

Adalimumab Monotherapy and a Combination with Azathioprine for Crohn’s Disease: A Prospective, Randomized Trial

Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica

A randomized trial of methotrexate versus azathioprine for severe atopic eczema

Efficacy of optimised thiopurine therapy in patients with moderate-to-severe ulcerative colitis: retrospective long-term follow-up from two randomised trials

Budesonide versus Prednisone with Azathioprine for the Treatment of Autoimmune Hepatitis in Children and Adolescents

A real‐world study focused on the long‐term efficacy of mycophenolate mofetil as first‐line treatment of autoimmune hepatitis

The efficacy and safety of immunosuppressive therapies in the treatment of IgA nephropathy: A network meta-analysis

Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximab

Mucosal Healing in Paediatric Patients with Moderate-to-Severe Luminal Crohn’s Disease Under Combined Immunosuppression: Escalation versus Early Treatment

Withdrawal of thiopurines in Crohn’s disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2)

Randomised clinical trial: individualised vs. weight‐based dosing of azathioprine in Crohn's disease

Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?

Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial

Immune thrombocytopenia: Effectiveness of frontline steroids and comparison of azathioprine, splenectomy, and rituximab as second‐line treatment

Azathioprine in severe uveitis of Behçet's disease

Concerns and Side Effects of Azathioprine During Adalimumab Induction and Maintenance Therapy for Japanese Patients With Crohn's Disease: A Subanalysis of a Prospective Randomised Clinical Trial [DIAMOND Study]

Belimumab in refractory organizing pneumonia associated with systemic lupus erythematosus: a case report

Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial

Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease

Azathioprine discontinuation earlier than 6 months in Crohn's disease patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation

Azathioprine Therapy in a Pediatric TPMT-Deficient Patient-Still an Option

Efficacy of Sustained Combination Therapy for at Least 6 Months with Thiopurines and Infliximab in Patients with Ulcerative Colitis in Clinical Remission: A Retrospective Multicenter French Experience

Treatment efficacy and safety of low-dose azathioprine in chronic active ulcerative colitis patients: A meta-analysis and systemic review

Aktive Filter

Suchergebnisse filtern